In Brief This Week: Luminex; Qiagen; Life Technologies; AvanDx; Monogram Biosciences; and CombiMatrix | GenomeWeb

NEW YORK (GenomeWeb News) – Luminex this week announced that it has opened a new office in Shanghai, People's Republic of China, to serve as its center of operations in the Asia-Pacific region. The firm said that the office will include training lab space and a full-time staff, though it did not provide an expected number of employees. Luminex also has operations at its headquarters in Austin, Texas, and offices in Toronto and Oosterhout, The Netherlands.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.